Key result
Evolocumab review evaluates clinical outcomes in patients with cardiovascular disease.
Key points are not available for this paper at this time.
Answers are grounded in this paper and cite their sources.
ClinicalEvolocumab and clinical outcomes in patients with cardiovascular disease s hadjiphilippou 1 , KK ray 2 Title evolocumab and clinical outcomes in patients with cardiovascular disease
No takes yet. Share an insight, caveat, or question.
Hadjiphilippou et al. (2017) studied this question. Evolocumab was reviewed for its effects on clinical outcomes in patients with cardiovascular disease.
Synapse has enriched 10 related papers. Consider them for comparative context: